Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Recurrence 1Ovarian Neoplasms 1Melanoma 1Locally Advanced Colorectal Cancer 1Gastric Adenocarcinoma 1Colorectal Cancer Metastatic 1

Interventions

apatinib 2disitamab vedotin 1SHR-1701 1S 1 (combination) 1Oxaliplatin 1Indocyanine Green 1Gastrectomy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Gastric Adenocarcinoma × SHR-1701 × Clear all
NCT07464756 2026-03-11

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting
80 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡